Advanced Life Sciences to Be Featured at BIO 2002 Business Forum

Woodridge, Ill, June 7, 2002 - Advanced Life Sciences is one of a select number of biotech companies that have been invited to make presentations before an international audience of investors, biotech CEOs, journalists and representatives of large pharmaceutical companies at BIO 2002 in Toronto on June 9-12, sponsored by the Biotechnology Industry Organization ( BIO 2002, the 16th Annual International Biotechnology Convention & Exhibition, is being held outside the United States for just the second time. More than 15,000 delegates from all over the world will participate in what will be the largest gathering ever for the biotechnology industry.

Advanced Life Sciences' presentation will be on June 11, 2002 at 9:15 AM (EST) in the Toronto Convention Centre. Michael T. Flavin, Ph.D., Chief Executive Officer of the Company will give the presentation. Based in Woodridge, Illinois, Advanced Life Sciences ( is a privately held drug development company that discovers and develops therapeutic compounds to fight infection, inflammation and cancer. The Company bridges the gap between drug discovery and pharmaceutical commercialization, and focuses on diseases that have significant unmet medical needs in important markets.

Advanced Life Sciences was selected from an elite pool of more than 420 applicants to present at the BIO 2002 Business Forum. The 230 presenting companies will describe their technologies, products and business plans during 15-minute presentations. This international investor and partnering forum offers the opportunity to greatly expand the awareness of exciting new products and companies in health-care, agricultural, industrial and environmental biotechnology. Companies selected to present at the Business Forum represent Australia, Austria, Canada, Denmark, Finland, France, Germany, Israel, the Netherlands, Switzerland, the United Kingdom and the United States.

# # #